Georgios V. Georgakis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Georgios V. Georgakis has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Aaron R. Sasson
Department of Anesthesiology, Renaissance School of Medicine at Stony Brook University, Stony Brook, New York
1 shared publication Arianna M. Ferretti
Renaissance School of Medicine at Stony, Brook University, Stony Brook, NY, USA
1 shared publicationChristina L. Wolchok
Stony Brook University Hospital
1 shared publication- Chun-Han Huang
Stony Brook Cancer Center, Stony Brook, Long Island, NY 11794, USA
1 shared publication - Claire Hagan Parker
Renaissance School of Medicine at Stony, Brook University, Stony Brook, NY, USA
1 shared publication David J. Restle
Department of Surgery, Stony Brook University Hospital, Stony Brook, NY, USA
1 shared publication
Latest Publications
- 17 March 2026
- Published by Springer Nature in Surgical Endoscopy
- Vol. 40 (4) , 2819-2829
Comparing oncologic and surgical outcomes of robotic and open pancreatoduodenectomy: an updated meta-analysis
To compare perioperative and oncologic outcomes of robotic pancreaticoduodenectomy (RPD) versus open pancreaticoduodenectomy (OPD) using evidence from cohort studies in a systematic review. This is a systematic review and meta-analysis comparing outcomes between RPD and OPD. Intraoperative outcomes were operative time, estimated blood loss, lymph node yield, R0 resection, and R1 resection. Post-operative outcomes were overall complication rates, Clavien-Dindo ≥ 3, post-operative pancreatic fistula, bile leak, delayed gastric emptying, post-pancreatectomy hemorrhage, wound infection, length of stay, re-admission, re-operation, short-term mortality, and long-term mortality. Fixed-effects model or random-effects model was used to pool results. Heterogeneity was assessed using I2 and Cochran's test. Publication bias was assessed using Egger's test. Influential test, outlier detection, and sensitivity analysis were conducted. Fourteen studies met inclusion criteria, including 2862 patients (1087 in the RPD group and 1775 in the OPD group). The RPD group was associated with longer operative times, less blood loss, lower risk of overall complications, long-term mortality, and short-term mortality, and shorter length of stay. No other significant differences in outcomes were detected between the groups. RPD achieved superior perioperative clinical outcomes and comparable oncologic outcomes. These findings suggest that robotic pancreatoduodenectomy may offer a promising alternative to open surgery.
- 17 March 2026
- Published by Springer Nature in Surgical Endoscopy
- Vol. 40 (4) , 2819-2829
Comparing oncologic and surgical outcomes of robotic and open pancreatoduodenectomy: an updated meta-analysis
To compare perioperative and oncologic outcomes of robotic pancreaticoduodenectomy (RPD) versus open pancreaticoduodenectomy (OPD) using evidence from cohort studies in a systematic review. This is a systematic review and meta-analysis comparing outcomes between RPD and OPD. Intraoperative outcomes were operative time, estimated blood loss, lymph node yield, R0 resection, and R1 resection. Post-operative outcomes were overall complication rates, Clavien-Dindo ≥ 3, post-operative pancreatic fistula, bile leak, delayed gastric emptying, post-pancreatectomy hemorrhage, wound infection, length of stay, re-admission, re-operation, short-term mortality, and long-term mortality. Fixed-effects model or random-effects model was used to pool results. Heterogeneity was assessed using I2 and Cochran's test. Publication bias was assessed using Egger's test. Influential test, outlier detection, and sensitivity analysis were conducted. Fourteen studies met inclusion criteria, including 2862 patients (1087 in the RPD group and 1775 in the OPD group). The RPD group was associated with longer operative times, less blood loss, lower risk of overall complications, long-term mortality, and short-term mortality, and shorter length of stay. No other significant differences in outcomes were detected between the groups. RPD achieved superior perioperative clinical outcomes and comparable oncologic outcomes. These findings suggest that robotic pancreatoduodenectomy may offer a promising alternative to open surgery.
- Open Access
- 22 June 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (13) , 6870
Development of a Radiolabeled Cyclin-Dependent Kinases 4 and 6 (CDK4/6) Inhibitor for Brain and Cancer PET Imaging
The synthesis, biochemical evaluation and radiosynthesis of a cyclin-dependent kinases 4 and 6 (CDK4/6) inhibitor and radioligand was performed. NT431, a newly synthesized 4-fluorobenzyl-abemaciclib, exhibited high potency to CDK4/6 and against four cancer cell lines with IC50 similar to that of the parent abemaciclib. We performed a two-step one-pot radiosynthesis to produce [18F]NT431 with good radiochemical yield (9.6 ± 3%, n = 3, decay uncorrected), high radiochemical purity (>95%), and high molar activity (>370 GBq/µmol (>10.0 Ci/µmol). In vitro autoradiography confirmed the specific binding of [18F]NT431 to CDK4/6 in brain tissues. Dynamic PET imaging supports that both [18F]NT431 and the parent abemaciclib crossed the BBB albeit with modest brain uptake. Therefore, we conclude that it is unlikely that NT431 or abemaciclib (FDA approved drug) can accumulate in the brain in sufficient concentrations to be potentially effective against breast cancer brain metastases or brain cancers. However, despite the modest BBB penetration, [18F]NT431 represents an important step towards the development and evaluation of a new generation of CDK4/6 inhibitors with superior BBB penetration for the treatment and visualization of CDK4/6 positive tumors in the CNS. Also, [18F]NT431 may have potential application in peripheral tumors such as breast cancer and other CDK4/6 positive tumors.
- 22 June 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (13) , 6870
Open AccessDevelopment of a Radiolabeled Cyclin-Dependent Kinases 4 and 6 (CDK4/6) Inhibitor for Brain and Cancer PET Imaging
The synthesis, biochemical evaluation and radiosynthesis of a cyclin-dependent kinases 4 and 6 (CDK4/6) inhibitor and radioligand was performed. NT431, a newly synthesized 4-fluorobenzyl-abemaciclib, exhibited high potency to CDK4/6 and against four cancer cell lines with IC50 similar to that of the parent abemaciclib. We performed a two-step one-pot radiosynthesis to produce [18F]NT431 with good radiochemical yield (9.6 ± 3%, n = 3, decay uncorrected), high radiochemical purity (>95%), and high molar activity (>370 GBq/µmol (>10.0 Ci/µmol). In vitro autoradiography confirmed the specific binding of [18F]NT431 to CDK4/6 in brain tissues. Dynamic PET imaging supports that both [18F]NT431 and the parent abemaciclib crossed the BBB albeit with modest brain uptake. Therefore, we conclude that it is unlikely that NT431 or abemaciclib (FDA approved drug) can accumulate in the brain in sufficient concentrations to be potentially effective against breast cancer brain metastases or brain cancers. However, despite the modest BBB penetration, [18F]NT431 represents an important step towards the development and evaluation of a new generation of CDK4/6 inhibitors with superior BBB penetration for the treatment and visualization of CDK4/6 positive tumors in the CNS. Also, [18F]NT431 may have potential application in peripheral tumors such as breast cancer and other CDK4/6 positive tumors.
- Open Access
Automated Assessment of Critical View of Safety in Laparoscopic Cholecystectomy
Cholecystectomy (gallbladder removal) is one of the most common procedures in the US, with more than 1.2M procedures annually. Compared with classical open cholecystectomy, laparoscopic cholecystectomy (LC) is associated with significantly shorter recovery period, and hence is the preferred method. However, LC is also associated with an increase in bile duct injuries (BDIs), resulting in significant morbidity and mortality. The primary cause of BDIs from LCs is misidentification of the cystic duct with the bile duct. Critical view of safety (CVS) is the most effective of safety protocols, which is said to be achieved during the surgery if certain criteria are met. However, due to suboptimal understanding and implementation of CVS, the BDI rates have remained stable over the last three decades. In this paper, we develop deep-learning techniques to automate the assessment of CVS in LCs. An innovative aspect of our research is on developing specialized learning techniques by incorporating domain knowledge to compensate for the limited training data available in practice. In particular, our CVS assessment process involves a fusion of two segmentation maps followed by an estimation of a certain region of interest based on anatomical structures close to the gallbladder, and then finally determination of each of the three CVS criteria via rule-based assessment of structural information. We achieved a gain of over 11.8% in mIoU on relevant classes with our two-stream semantic segmentation approach when compared to a single-model baseline, and 1.84% in mIoU with our proposed Sobel loss function when compared to a Transformer-based baseline model. For CVS criteria, we achieved up to 16% improvement and, for the overall CVS assessment, we achieved 5% improvement in balanced accuracy compared to DeepCVS under the same experiment settings.
Open AccessAutomated Assessment of Critical View of Safety in Laparoscopic Cholecystectomy
Cholecystectomy (gallbladder removal) is one of the most common procedures in the US, with more than 1.2M procedures annually. Compared with classical open cholecystectomy, laparoscopic cholecystectomy (LC) is associated with significantly shorter recovery period, and hence is the preferred method. However, LC is also associated with an increase in bile duct injuries (BDIs), resulting in significant morbidity and mortality. The primary cause of BDIs from LCs is misidentification of the cystic duct with the bile duct. Critical view of safety (CVS) is the most effective of safety protocols, which is said to be achieved during the surgery if certain criteria are met. However, due to suboptimal understanding and implementation of CVS, the BDI rates have remained stable over the last three decades. In this paper, we develop deep-learning techniques to automate the assessment of CVS in LCs. An innovative aspect of our research is on developing specialized learning techniques by incorporating domain knowledge to compensate for the limited training data available in practice. In particular, our CVS assessment process involves a fusion of two segmentation maps followed by an estimation of a certain region of interest based on anatomical structures close to the gallbladder, and then finally determination of each of the three CVS criteria via rule-based assessment of structural information. We achieved a gain of over 11.8% in mIoU on relevant classes with our two-stream semantic segmentation approach when compared to a single-model baseline, and 1.84% in mIoU with our proposed Sobel loss function when compared to a Transformer-based baseline model. For CVS criteria, we achieved up to 16% improvement and, for the overall CVS assessment, we achieved 5% improvement in balanced accuracy compared to DeepCVS under the same experiment settings.
- Open Access
- 1 May 2022
- Published by Wolters Kluwer Health in ACG Case Reports Journal
- Vol. 9 (5) , e00773
Inverted Meckel's Diverticulum Masquerading as a Subepithelial Tumor of the Ileum
We describe a case of an inverted Meckel's diverticulum presenting as an intraluminal subepithelial lesion on intraoperative enteroscopy. A 53-year-old woman presented with chronic iron deficiency anemia unresponsive to escalating iron supplementation. After equivocal upper and lower endoscopy and negative cross-sectional imaging, capsule endoscopy suggested a submucosal mass lesion in the proximal ileum. Antegrade double-balloon enteroscopy was unsuccessful in reaching the lesion. A large pedunculated, submucosal-appearing lesion was finally identified on intraoperative enteroscopy. The mass was surgically resected, and final pathology confirmed an inverted Meckel's diverticulum.
- 1 May 2022
- Published by Wolters Kluwer Health in ACG Case Reports Journal
- Vol. 9 (5) , e00773
Open AccessInverted Meckel's Diverticulum Masquerading as a Subepithelial Tumor of the Ileum
We describe a case of an inverted Meckel's diverticulum presenting as an intraluminal subepithelial lesion on intraoperative enteroscopy. A 53-year-old woman presented with chronic iron deficiency anemia unresponsive to escalating iron supplementation. After equivocal upper and lower endoscopy and negative cross-sectional imaging, capsule endoscopy suggested a submucosal mass lesion in the proximal ileum. Antegrade double-balloon enteroscopy was unsuccessful in reaching the lesion. A large pedunculated, submucosal-appearing lesion was finally identified on intraoperative enteroscopy. The mass was surgically resected, and final pathology confirmed an inverted Meckel's diverticulum.
- 5 February 2019
- Published by Springer Nature
- p. 165-167
Management of Gastric Cancer